News

People impacted by fires in Northwest Territories are encouraged to register with the Canadian Red Cross

Registration with Red Cross ensures people can be notified as services may become availableOTTAWA, Aug. 18, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Pacific Health Care Organization, Inc. Reports its Results for the Period ended June 30, 2023

Irvine, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Results The Company reported net income of $176,427 or $0.01 per basic and…

1 year ago

Empower Clinics Provides Corporate Update

VANCOUVER, BC / ACCESSWIRE / August 18, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated…

1 year ago

Wisconsin’s Pioneering Pathway Seeks to Secure Tech Hub Designation in Personalized Medicine

Madison, Wisconsin--(Newsfile Corp. - August 18, 2023) - Building on Wisconsin's statewide position of strength in personalized medicine, biohealth technology,…

1 year ago

cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products

Washington, D.C.--(Newsfile Corp. - August 18, 2023) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of…

1 year ago

Preliminary Clinical Trial Presentation for Stem Cell and Dementia Held by Beauty-Stem Biomedical and Tzu Chi Hospital in Los Angeles, CA

First stem cell clinical trial landscape is revolutionized by Beauty-Stem Biomedical and Taiwan Tzu Chi Hospital, unveiling the progress of…

1 year ago

Nushape Unveils the Therapy Mat: Your Ultimate Portable Partner for Holistic Wellness

LEWES, DE / ACCESSWIRE / August 18, 2023 / Nushape, a pioneer in holistic health solutions, is thrilled to introduce…

1 year ago

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced the successful…

1 year ago

Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials

MB22001 has been manufactured ready for use in Phase 2 clinical trialsWorld first take-home approvals for psychedelic microdosingVANCOUVER, BC /…

1 year ago